⌘K

Home/Filings/4/0001493152-22-019872

4//SEC Filing

Ohri Manu 4

Accession 0001493152-22-019872

CIK 0000109657other

View on SEC.gov Company Profile

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 9:44 PM ET

Size

10.4 KB

Accession

0001493152-22-019872

Insider Transaction Report

Form 4

Period: 2022-07-15

GT Biopharma, Inc.GTBP

Chief Financial Officer

Transactions

Award
Option to purchase Common Stock
2022-07-15+200,000→ 200,000 total
Exercise: $2.48Exp: 2032-07-14→ Common Stock (200,000 underlying)
Award
Common Stock
2022-07-15+100,000→ 100,000 total
Other
Common Stock
2022-07-15−100,000→ 0 total
Other
Common Stock
2022-07-15+100,000→ 100,000 total(indirect: By Anarjay Concepts, Inc.)

Footnotes (2)

[F1]The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.
[F2]66,666 shares on the date of grant, and 66,667 shares on each February 14, 2023 and 2024.

Documents

1 file

4
ownership.xmlPrimary

Issuer

GT Biopharma, Inc.

CIK 0000109657

Entity typeother

Related Parties

1

filerCIK 0001424683

Filing Metadata

Form type: 4
Filed: Jul 18, 8:00 PM ET
Accepted: Jul 19, 9:44 PM ET
Size: 10.4 KB

View on SEC.gov